US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

80.30

-0.1600-0.20%

Post-market: 80.910.6060+0.75%16:55 EDT

Volume:279.27K

Turnover:22.45M

Market Cap:3.37B

PE:- -

High:81.19

Open:81.03

Low:80.21

Close:80.46

52wk High:85.46

52wk Low:64.30

Shares:42.00M

Float Shares:42.00M

Volume Ratio:0.55

T/O Rate:0.66%

Dividend:1.02

Dividend Rate:1.27%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Scotiabank Remains a Buy on AbbVie (ABBV)

UnitedHealth (UNH) Gets a Buy from Bernstein

Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating

MT Newswires Live

AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results

Summit Therapeutics Says it is Beating Merck with Its Cancer Drug

AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints

MT Newswires Live

AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study

AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS

AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals

Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26

THOMSON REUTERS

Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections

THOMSON REUTERS

Abbvie - Etentamig Achieves 74% Orr and 60% Risk Reduction in Phase 3 Cervino Trial

THOMSON REUTERS

Abbvie Announces Positive Topline Results from the Phase 3 Cervino Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS

AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics

MT Newswires Live

Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/FHLC/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FHLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","market":"US","secType":"STK","nameCN":"Fidelity MSCI Health Care Index ETF","latestPrice":80.3,"timestamp":1789156800000,"preClose":80.46,"halted":0,"volume":279266,"hourTrading":{"tag":"盘后","latestPrice":80.906,"preClose":80.3,"latestTime":"16:55 EDT","volume":22,"amount":1767.6859200000001,"timestamp":1789160122592,"change":0.606,"changeRate":0.007547,"amplitude":0.014197},"delay":0,"changeRate":-0.0019885657469549665,"floatShares":42000000,"shares":42000000,"eps":0,"marketStatus":"Post-Mkt","change":-0.16,"latestTime":"09-11 17:29:22 EDT","open":81.03,"high":81.19,"low":80.213,"amount":22454687.129940003,"amplitude":0.012143,"askPrice":87.78,"askSize":100,"bidPrice":79.01,"bidSize":5,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":80.46,"sharesOutstanding":39450000,"nav":80.970611,"aum":3400765662,"dividendRate":0.012725,"bidAskSpread":0.000344,"preHourTrading":{"tag":"盘前","latestPrice":82.03,"preClose":80.46,"latestTime":"08:49 EDT","volume":6,"amount":484.329984,"timestamp":1789130971970,"change":1.57,"changeRate":0.019513,"amplitude":0.019513},"postHourTrading":{"tag":"盘后","latestPrice":80.906,"preClose":80.3,"latestTime":"16:55 EDT","volume":22,"amount":1767.6859200000001,"timestamp":1789160122592,"change":0.606,"changeRate":0.007547,"amplitude":0.014197},"volumeRatio":0.549345,"impliedVol":0.1507,"impliedVolPercentile":0.8247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FHLC\",,,,,undefined,":{"symbol":"FHLC","floatShares":42000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.549345,"shares":42000000,"dividePrice":1.0218,"high":81.19,"amplitude":0.012143,"preClose":80.46,"low":80.213,"week52Low":64.3,"pbRate":"--","week52High":85.4649,"institutionHeld":0,"latestPrice":80.3,"committee":-0.904762,"eps":0,"divideRate":0.012725,"volume":279266,"delay":0,"ttmEps":0,"open":81.03,"prevYearClose":74.28,"prevWeekClose":83.14,"prevMonthClose":82.73,"prevQuarterClose":77.25,"fiveDayClose":84,"twentyDayClose":81.73,"sixtyDayClose":73.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FHLC\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"FHLC","amount":0.263,"announcedDate":"2026-06-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-23"},{"date":"2026-03-20","symbol":"FHLC","amount":0.229,"announcedDate":"2026-03-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-24","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-24"},{"date":"2025-12-19","symbol":"FHLC","amount":0.272,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-23"},{"date":"2025-09-19","symbol":"FHLC","amount":0.256,"announcedDate":"2025-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-19","defaultRemindTime":1758288600000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-19","currency":"USD","dateTimestamp":1758254400000,"payDate":"2025-09-23"},{"date":"2025-06-20","symbol":"FHLC","amount":0.257,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-20","defaultRemindTime":1750426200000,"name":"Fidelity MSCI Health Care Index","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-24","payableDate":"2025-06-20","currency":"USD","dateTimestamp":1750392000000,"payDate":"2025-06-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FHLC\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-22","value":0.121,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-22","value":0.117,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-23","value":0.125,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-22","value":0.137,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-20","value":0.132,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FHLC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FHLC\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664339449","title":"Scotiabank Remains a Buy on AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339449","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339449?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:35","pubTimestamp":1788521731,"startTime":"0","endTime":"0","summary":"In a report released today, Louise Chen from Scotiabank maintained a Buy rating on AbbVie, with a price target of $280.00. Chen covers the Healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0738911758.USD","LU0553294199.USD","LU0472753341.HKD","LU0949170772.SGD","PJP","LU1291159041.SGD","IE00BLSP4239.USD","LU1057294990.SGD","LU1236620834.HKD","LU1983299246.USD","JDOC","LU1839511570.USD","LU1923622614.USD","LU2237443622.USD","SG9999015978.USD","IYH","ABBV","PPH","LU2129689605.HKD","LU1267930573.SGD","LU2347655073.USD","LU2023251221.USD","LU0029864427.USD","LU0057025933.USD","LU0114720955.EUR","LU1162221912.USD","LU0689472784.USD","LU0689626769.HKD","LU0820561818.USD","RXL","LU0128525929.USD","LU2433249047.HKD","LU0965508806.USD","FTXH","IE000MB6IJN5.SGD","VHT","LU2237443978.SGD","LU1670627923.USD","LU1267930490.SGD","MEDX","IXJ","AGNG","LU1244550221.USD","LU2468319806.SGD","SG9999011175.SGD","GLAM","LU0859254822.USD","TRUH","FHLC","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664393983","title":"UnitedHealth (UNH) Gets a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2664393983","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664393983?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:17","pubTimestamp":1788520635,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes maintained a Buy rating on UnitedHealth today and set a price target of $512.00. According to TipRanks, Wilkes is a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/unitedhealth-unh-gets-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/unitedhealth-unh-gets-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","LU0316494557.USD","IE00B19Z8X17.USD","LU1066051225.USD","LU2324357040.USD","LU0128525689.USD","LU2361044865.SGD","LU0965509010.AUD","LU1035773651.USD","LU0251132253.USD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU0109391861.USD","IE00BSNM7G36.USD","LU0289739699.SGD","LU1674673428.USD","LU1267930573.SGD","IE00BJJMRZ35.SGD","BK4533","UNH","LU1267930227.SGD","SG9999001176.SGD","IE00B19Z9P08.USD","BK4588","LU2236285917.USD","LU2362541513.USD","BK4534","LU0820562030.AUD","SG9999017495.SGD","IE00BJJMRX11.SGD","LU0107464264.USD","LU1934455194.USD","IE00BKVL7J92.USD","LU2357305700.SGD","LU2362540622.SGD","LU0342679015.USD","LU1267930730.SGD","LU1934455863.HKD","LU2279689827.SGD","SG9999002224.SGD","IE00B775H168.HKD","UNHW","LU0079474960.USD","SG9999002232.USD","LU1732800096.USD","IE0004445015.USD","LU0077335932.USD","LU1023059063.AUD","LU1778281490.HKD","XLV","LU0672654240.SGD","LU1989771016.USD","LU1732799900.SGD","LU0238689110.USD","HRTS","LU2461242641.AUD","IHF","LU0203345920.USD","LU0211326839.USD","LU0345770993.USD","LU0689472784.USD","LU0211326755.USD","LU0861579265.USD","LU1506573853.SGD","LU2361044949.HKD","LU2347655156.SGD","IE00B2B36J28.USD","LU2468319806.SGD","LU0708995401.HKD","MHIP","LU1983299246.USD","SG9999014906.USD","UNHU","FHLC","LU0976567544.SGD","SG9999014898.SGD","LU0557290698.USD","LU0058720904.USD","LU0795875169.SGD","LU0203347892.USD","IE0002141913.USD","IE00B19Z3581.USD","LU0029864427.USD","LU1066053197.SGD","LU0198837287.USD","LU0354030438.USD","LU1069347547.HKD","LU1914381329.SGD","LU2954938101.SGD","LU1064131342.USD","IE00B4JS1V06.HKD","IE00BJT1NW94.SGD","IE00BN29S564.USD","LU1084165304.USD","LU0094547139.USD","SG9999018865.SGD","UNHG","IE00BZ1G4Q59.USD","LU0162691827.USD","LU1323610961.USD","LU2087625088.SGD","LU1551013342.USD","LU2360032135.SGD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU0882574055.USD","LU2552382215.SGD","LU1720051017.SGD","TMED","LU0683600562.USD","RXL","IYH","LU2552382132.HKD","LU0965509283.SGD","LU0011850046.USD","LU0661504455.SGD","LU2491050154.USD","LU1670628061.USD","LU2242649171.HKD","IE00B1XK9C88.USD","LU0234572021.USD","VHT","LU0820561909.HKD","LU0158827781.USD","LU0708994859.HKD","IXJ","LU0353189680.USD","BK4154","LU0354030511.USD","LU1674673691.USD","LU1854103824.USD","LU2491049909.HKD","IE00B894F039.SGD","IE00BKPKM429.USD","LU2211815571.USD","SG9999014880.SGD","LU1153585028.USD","IE00BZ9MQY76.HKD","LU0943347566.SGD","LU1988902786.USD","LU1066051498.USD","BK4581","IE0009355771.USD","IE00BFSS8Q28.SGD","LU2125154935.USD","LU0496365809.HKD","LU1548497426.USD","LU1261432733.SGD","LU0417517546.SGD","LU2133065610.SGD","LU1119994496.HKD","LU2089984988.USD","LU0128525929.USD","LU1267930490.SGD","SGXZ99366536.SGD","LU2491050071.SGD","IE00B3T34201.USD","LU1718418525.SGD","LU0187121727.USD","LU2244417387.USD","SG9999013999.USD","IE00B19Z9505.USD","LU0949170772.SGD","JDOC","SUNH0main","LU0053666078.USD","LU0345770308.USD","LU2089284900.SGD","LU0456855351.SGD","LU1037948541.HKD","LU1551013425.SGD","SGXZ57979304.SGD","LU0158827948.USD","LU2417539215.USD","LU1934455277.USD","LU2456880835.USD","LU1003077747.HKD","LU0823416689.USD","LU0912757837.SGD","TRUH","LU0553294199.USD","LU0787776722.HKD","BK4585","LU0143551892.USD","SGXZ81514606.USD","LU2112291526.USD","LU0310800965.SGD","LU1061106388.HKD","LU0965509101.SGD","LU1074936037.SGD","LU0795875086.SGD","SGXZ51526630.SGD","IE000M9KFDE8.USD","LU1066051811.HKD","SG9999018857.SGD","IE0005OL40V9.USD","LU1791710582.SGD","LU2271345857.HKD","IE00BFSS7M15.SGD","IE00B19Z9Z06.USD","LU0097036916.USD","IE00BJJMRY28.SGD","LU0965508806.USD","LU2023251221.USD","IE00B19Z8W00.USD","LU2361045086.USD","LU1791710400.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU0310800379.SGD","LU0211328371.USD","BK4566","LU2125154778.USD","LU1496350502.SGD","BK4532","LU0320765059.SGD","LU0310799852.SGD","LU0820561818.USD","LU0211327993.USD","LU1854104046.USD","LU2552382058.USD","IE0004445239.USD","IE00B7SZLL34.SGD","LU0432979614.USD","SGXZ31699556.SGD","LU0048584097.USD","LU2089283258.USD","IE0002270589.USD","LU0149725797.USD","LU0738911758.USD","LU2264538146.SGD","LU2462591277.SGD","LU0545039389.USD","SG9999014914.USD","LU1291159041.SGD","SG9999001176.USD","IE00BFXG1179.USD","LU0353189763.USD","LU0266013472.USD","LU1057294990.SGD","LU1814569148.SGD","LU1037948897.HKD","LU2028103732.USD","UN","LU0528227936.USD","LU2111349929.HKD","IE00B1BXHZ80.USD","LU0052756011.USD","LU0072461881.USD","LU0256863811.USD","LU1670627923.USD","LU0114720955.EUR","LU2999663052.SGD","LU2362541273.HKD","LU1720051108.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333359","title":"Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333359","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664333359?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:31","pubTimestamp":1788514300,"startTime":"0","endTime":"0","summary":"Merck & Co. (MRK) has an average rating of overweight and mean price target of $149.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2361045086.USD","LU2433249047.HKD","LU0477156953.USD","IE0009355771.USD","RXL","SG9999013999.USD","IYH","LU1291159041.SGD","LU0106261372.USD","LU1162221912.USD","LU1430594728.SGD","LU0320765646.SGD","LU0320765489.SGD","LU2125909593.SGD","LU0965509010.AUD","IE00BJT1NW94.SGD","PAWZ","LU1066053197.SGD","LU1941712264.USD","LU1941712348.USD","LU2360032135.SGD","LU1037948897.HKD","LU1989772840.SGD","BK4550","LU0208291251.USD","BMED","IE00BLSP4452.SGD","LU2023250843.SGD","LU1699723380.USD","LU0965508806.USD","LU2461242641.AUD","IE0002141913.USD","LU0648001328.SGD","SG9999001176.SGD","SG9999014559.SGD","SG9999002232.USD","LU0122379950.USD","LU0859254822.USD","HRTS","FTXH","LU2468319806.SGD","LU1201861249.SGD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU0942090050.USD","LU0861579265.USD","IXJ","LU1983299246.USD","LU0868494708.USD","LU0203345920.USD","PPH","LU1974910355.USD","LU1093756325.SGD","LU0985320562.USD","LU1929549753.HKD","LU2112291526.USD","IE00B4R5TH58.HKD","BK4588","MRK","LU0689626769.HKD","FHLC","BK4516","LU0124676726.USD","LU1989772923.USD","BK4534","LU0266013472.USD","LU0234572021.USD","BK4007","LU0980610538.SGD","IE00BBT3K403.USD","LU1093756168.USD","TRUH","LU2361044949.HKD","SG9999015341.SGD","LU0238689110.USD","LU0432979614.USD","LU0868494617.USD","LU1035773651.USD","LU1585245621.USD","SG9999001176.USD","LU1061106388.HKD","BK4585","LU2125154935.USD","LU1066051225.USD","SG9999002224.SGD","LU1032466523.USD","LU1057294990.SGD","LU1066051811.HKD","LU0265550359.USD","LU2491050071.SGD","LU1069347547.HKD","LU1934455194.USD","JDOC","LU0289739699.SGD","LU2324357040.USD","XLV","LU1571399168.USD","IE00BN8TJ469.HKD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU1923622614.USD","BK4533","SG9999015358.SGD","LU2125154778.USD","LU2361044865.SGD","SG9999014575.USD","LU0130517989.USD","LU1116320737.USD","LU0265550946.USD","IE00BFTCPJ56.SGD","LU0006306889.USD","SG9999014567.USD","LU0965509283.SGD","GDOC","IHE","LU1989771016.USD","IE00BSNM7G36.USD","LU0203347892.USD","LU1066051498.USD","LU2089984988.USD","LU0965509101.SGD","LU1934455277.USD","LU1037948541.HKD","BK4559","IE00BJJMRZ35.SGD","LU2023250504.SGD","SG9999001440.SGD","IE000M9KFDE8.USD","LU0130102774.USD","SG9999014542.SGD","LU2491050154.USD","LU1934455863.HKD","LU1116320901.HKD","LU0058720904.USD","LU1917777945.USD","IE00B2B36J28.USD","LU0211331839.USD","LU2491049909.HKD","LU0098860793.USD","LU2357627491.SGD","LU2125909247.SGD","LU1023059063.AUD","VHT","LU0823416689.USD","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127014248","title":"AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1127014248","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127014248?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:44","pubTimestamp":1788486257,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE: ABBV) announced on Thursday that it has finalized its $10.9 billion acquisition of inflammation drug developer Apogee Therapeutics (NASDAQ: APGE). This transaction marks the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","SG9999015952.SGD","MYLD","IE00BGHQF631.EUR","LU0661504455.SGD","IE00BFTCPJ56.SGD","IE00BDGV0183.EUR","APGE","IE00BLSP4452.SGD","LU0158827948.USD","SG9999015986.USD","LU2237443465.HKD","LU0256863902.USD","IE00B4R5TH58.HKD","LU0203347892.USD","SG9999011175.SGD","LU0310799852.SGD","PPH","IE000MB6IJN5.SGD","LU1430594728.SGD","LU1003077747.HKD","LU2089283258.USD","LU0170899867.USD","IE00B3PB1722.GBP","LU2129689605.HKD","LU0289739699.SGD","IE0002141913.USD","LU1496350502.SGD","FTXH","LU1037948541.HKD","LU0098860793.USD","LU0738911758.USD","LU0868494617.USD","LU1732800096.USD","LU0545039389.USD","LU0949170772.SGD","LU0057025933.USD","IE00B19Z3B42.SGD","IE00BN8TJ469.HKD","LU0456855351.SGD","LU1074936037.SGD","LU1267930573.SGD","LU0472753341.HKD","LU0726765562.USD","IE00BBT3K403.USD","LU0128525929.USD","IE00BJJMRZ35.SGD","LU2087621335.USD","LU0859254822.USD","BK4139","LU2133065610.SGD","LU0965508806.USD","LU1551013342.USD","LU1989772840.SGD","LU0289739343.SGD","LU0211327993.USD","CALF","SG9999003800.SGD","IXJ","LU1057294990.SGD","LU0198837287.USD","BK4581","BK4534","IE000SO60NU8.SGD","LU2237443978.SGD","IE000BZT7R73.USD","LU1093756168.USD","LU0114720955.EUR","LU1839511570.USD","LU0053671581.USD","LU1718418525.SGD","LU1934455863.HKD","LU1244550494.USD","RXL","IE00BVYPNW00.USD","ABBV","LU2129689431.USD","LU1670628061.USD","LU1989771016.USD","LU2237443549.SGD","LU0689626769.HKD","LU2237443382.USD","IE0009355771.USD","LU1236620834.HKD","LU0882574055.USD","LU1585245621.USD","IE000F7OJYX1.SGD","LU0256863811.USD","GLAM","LU0029864427.USD","LU0234572021.USD","IE00B42XCP33.USD","LU2125909247.SGD","LU1929549753.HKD","JDOC","LU0320765646.SGD","LU2023251221.USD","LU0795875169.SGD","LU0823416689.USD","LU2237443622.USD","LU0069063385.USD","LU0289961442.SGD","LU2125909593.SGD","LU1934455194.USD","LU0820561909.HKD","LU0122379950.USD","LU1162221912.USD","IE00BLSP4239.USD","AGNG","LU0868494708.USD","LU0965509101.SGD","LU0943347566.SGD","SG9999015978.USD","LU2357627491.SGD","LU1670627923.USD","LU1244550221.USD","IYH","BK4588","LU0432979614.USD","IE00B2B36J28.USD","LU0820561818.USD","IE000WAW04H5.SGD","VHT","LU1061106388.HKD","SBIO","IE00BVYPNV92.GBP","LU0058720904.USD","LU1291159041.SGD","IE00BSNM7G36.USD","KCE","LU1037948897.HKD","LU0211328371.USD","LU2347655156.SGD","LU1732799900.SGD","LU0795875086.SGD","XMMO","TRUH","LU2089984988.USD","IE00B19Z3581.USD","LU0965509283.SGD","LU1244550577.SGD","LU1989772923.USD","LU2468319806.SGD","MEDX","SG9999015945.SGD","LU1023059063.AUD","LU2129689514.USD","LU0861579265.USD","FHLC","LU2433249047.HKD","LU1551013425.SGD","LU0965509010.AUD","BK4566","LU0124676726.USD","LU1236620750.USD","LU1093756325.SGD","LU1267930490.SGD","LU0234570918.USD","SG9999001440.SGD","LU0912757837.SGD","LU0203345920.USD","LU2112291526.USD","BK4585","IE0004445239.USD","IE00BJT1NW94.SGD","LU0511384066.AUD","LU0553294199.USD","LU0708994859.HKD","LU0689472784.USD","LU1983299246.USD","LU1934455277.USD","LU0395794307.EUR","LU2347655073.USD","BK4533","LU0417517546.SGD","XLV","IE0000B7K699.USD","LU1923622614.USD","LU2089284900.SGD","LU2237443895.HKD","BK4559","PJP","LU0985320562.USD","LU1496350171.SGD","IE0002270589.USD","LU0310800379.SGD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804473","title":"Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804473","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804473?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:29","pubTimestamp":1788470940,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slipped 1.52% to $14.27 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.06% to 7,747.71 and the Dow Jones Industrial Average  rising 1.18% to 53,686.11.Perrigo Co. PLC closed 39.74% below its 52-week high of $23.68, which the company achieved on September 5th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.17% to $278.43, Procter & Gamble Co.  fell 0.49% to $146.92, and Abbott Laboratories  fell 1.52% to $108.79.Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUO","PJP","LU1989763690.USD","LU1244550577.SGD","IE000M9KFDE8.USD","LU0266013472.USD","LU1145028129.USD","LU2211815571.USD","UGE","SG9999013999.USD","IE000SO60NU8.SGD","IHI","GDOC","IE0000B7K699.USD","XLP","FSTA","LU0795875169.SGD","SG9999002232.USD","LU0234572021.USD","VHT","LU2237957902.USD","FHLC","RXL","XLV","PG","BMED","TRUH","LU0114720955.EUR","LU2487616109.SGD","IE00BSNM7G36.USD","MEDX","SG9999001176.SGD","JDOC","LU1868836757.USD","BK4566","PRGO","IHE","ABT","LU2756315664.SGD","IE00BVYPNW00.USD","LU0820561818.USD","FTXH","IXJ","TMED","BK4581","LU1914381329.SGD","IYH","IE00BFMHRM44.USD","JNJ","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809829","title":"Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809829?lang=en_us&edition=fundamental","pubTime":"2026-09-04 02:48","pubTimestamp":1788461317,"startTime":"0","endTime":"0","summary":"JPMorgan Chase ($JPM) is pounding the table on the stock of pharmaceutical giant Eli Lilly ($LLY) as sales of its weight-loss drugs accelerate. Chr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gets-a-bullish-note-from-jpmorgan-chase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gets-a-bullish-note-from-jpmorgan-chase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B775H168.HKD","LU2023250330.USD","LU1267930730.SGD","LU0070302665.USD","LU0211328371.USD","THNR","BK4534","SG9999014880.SGD","IE00BJLML261.HKD","XLV","BK4585","SG9999002224.SGD","IE00BJTD4V19.USD","LU0971096721.USD","IXJ","LU0211327993.USD","IE00BFTCPJ56.SGD","LU0174119429.USD","LU1366333091.USD","LU0215105999.USD","LU1244550494.USD","IE0034235295.USD","IE00BJJMRY28.SGD","IE0001KFT4U8.USD","JPO","BK4599","IE00BKVL7J92.USD","IE00BKDWB100.SGD","LU0048584097.USD","LU0198837287.USD","ELIS","LU1720051017.SGD","IE00BFSS8Q28.SGD","XLF","LU0211326755.USD","BK4207","IE00BK4W5L77.USD","LU2213496289.HKD","LU0320765059.SGD","LU1974910355.USD","SG9999015945.SGD","LU0006306889.USD","IYF","LU1057294990.SGD","LU1280957306.USD","LU0208291251.USD","LU2063271972.USD","LU0496365809.HKD","LU0417517546.SGD","LU2264538146.SGD","CURE","LU1267930490.SGD","WDNA","LU2237443622.USD","BK4588","LU0256863902.USD","IE00BJJMRX11.SGD","LU2108987350.USD","LU0471298777.SGD","IE0004445015.USD","LU2456880835.USD","LU1069344957.HKD","MHIP","RXL","LU0106261372.USD","IE00B4JS1V06.HKD","SG9999013999.USD","LLYZ","IE00BJT1NW94.SGD","LU0689472784.USD","LU1116320901.HKD","KBWB","LU2471134879.HKD","LU2361044865.SGD","LU1979441026.SGD","LU0943347566.SGD","LU0345769631.USD","LU0187121727.USD","LU1670627923.USD","LU1712237335.SGD","LU1691799644.USD","LU0256863811.USD","LU0316494557.USD","LU2168563687.JPY","IE00BDRTCR15.USD","LU0234572021.USD","LU2462591350.SGD","LU1983299246.USD","LU2750360997.AUD","LU2112291526.USD","CANC","LU0640476718.USD","LU1093756168.USD","LU0432979614.USD","LU2417539215.USD","LU0466842654.USD","SG9999001176.SGD","SG9999018865.SGD","LU2168564149.EUR","IE00B1BXHZ80.USD","LU2746668461.USD","LU0267386448.USD","IE0002141913.USD","LU0823434740.USD","LU2237438978.USD","LU1868836757.USD","LU1868836591.USD","LU1720051108.HKD","LU0170899867.USD","IE00BHPRN162.USD","LU1496350502.SGD","LU2236285917.USD","LU2054465674.USD","BK4516","LU0061475181.USD","IE00BN29S564.USD","LU2237443895.HKD","IE00BJJMRZ35.SGD","LU0882574139.USD","IYH","SGXZ51526630.SGD","FHLC","SGXZ57979304.SGD","IE0005OL40V9.USD","LU0133085943.USD","LU0203202063.USD","LU0786609619.USD","IE00BJTD4N35.SGD","LU2087625088.SGD","LU0149725797.USD","MEDI","FNCL","LU1551013425.SGD","LU1064131342.USD","IE00BKPKM429.USD","LU2750360641.GBP","LU0471298694.HKD","LU0820562030.AUD","BK4533","LU0225283273.USD","LU0238689110.USD","LU2381873111.SGD","JPM","LU0203345920.USD","LU2430703251.USD","LU1868836914.USD","MEDX","OZEM","SG9999015986.USD","LU0354030438.USD","LU2237443549.SGD","BK4566","LU0868494617.USD","JDOC","LU2089284900.SGD","LLYX","IE00BK4W5M84.HKD","LU2237443382.USD","IE00B7KXQ091.USD","LU2168564495.EUR","IE00B1XK9C88.USD","LU0157215616.USD","LU2168564065.EUR","LU1232071149.USD","LU2023250843.SGD","IE0009355771.USD","LU2361044949.HKD","LU1917777945.USD","LU0320765992.SGD","LU1989771016.USD","TRUF","LU1668664300.SGD","LU2211815571.USD","LU0158827948.USD","SG9999002232.USD","LU1814569148.SGD","IE00BFSS7M15.SGD","LU0823416689.USD","LU2746668974.SGD","LU2237443978.SGD","LU0976567544.SGD","LU1116320737.USD","IE00BWXC8680.SGD","LU2023250504.SGD","TFNS","LU2357305700.SGD","LU2168564222.USD","LU2089283258.USD","LU1868837300.USD","LU2237443465.HKD","LU0251132253.USD","SGXZ31699556.SGD","LU0211331839.USD","IE00BFXG1179.USD","FTXO","LU1551013342.USD","SG9999015978.USD","LU0096364046.USD","LU0310799852.SGD","IE00B3S45H60.SGD","LU1244550577.SGD","LU2271345857.HKD","LU2471134523.USD","LU1868837136.USD","LU0094547139.USD","LU0265550946.USD","LU0345769128.USD","LU1244550221.USD","LU2505996681.GBP","BK4550","LU1366192091.USD","LU2468319806.SGD","LU2357627491.SGD","SG9999017495.SGD","LU2265009873.SGD","LU0320765489.SGD","LU0823434583.USD","LU1804176565.USD","SGXZ81514606.USD","LU1670628061.USD","IE00B2B36J28.USD","LU1162221912.USD","IE00BDCRKT87.USD","IE00BN8TJ469.HKD","LU2430703095.HKD","IE0004445239.USD","BK4007","LU0456855351.SGD","LU2361045086.USD","LU0158827781.USD","IE00B775SV38.USD","VHT","SG9999014898.SGD","LU0114720955.EUR","SG9999014914.USD","GB00BDT5M118.USD","LU1035775433.USD","LU0820561818.USD","LU1127390331.HKD","LU1894683348.USD","SG9999014906.USD","LU0787776722.HKD","LU2023251221.USD","LU1363072403.SGD","LU0320765646.SGD","LU2471134952.CNY","LU2430703178.SGD","LU2028103732.USD","LU2552382058.USD","LU0672654240.SGD","LU0210536198.USD","LLY","LU2089984988.USD","LU2756315664.SGD","LU1629891620.HKD","IE00BLSP4239.USD","LU0079474960.USD","LU0859254822.USD","LU0203347892.USD","IE00BZ1G4Q59.USD","LU0097036916.USD","SG9999001176.USD","LU0868494708.USD","IE00BBT3K403.USD","LU0942090050.USD","LU0683600562.USD","LU2491049909.HKD","LU2471134796.USD","LU0234570918.USD","TRUH","LU0211326839.USD","IE0034235188.USD","LU2462157665.USD","LU1145028129.USD","LU0266013472.USD","LU0109391861.USD","SG9999018857.SGD","LU0203201768.USD","FTXH","LU2461242641.AUD","IXG","LU1093756325.SGD","HRTS","LU0345770308.USD","LU0109394709.USD","LU2242649171.HKD","LU1119994496.HKD","BK4504","ILDR","IE0034235303.USD","SG9999015952.SGD","LU1623119135.USD","LU0289739699.SGD","LU1261432733.SGD","LU0964807845.USD","LU1548497426.USD","LU0265550359.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","UYG","ELIL","LU0820561909.HKD","LU1032466523.USD","LU2360106947.USD","IE00BLSP4452.SGD","LU2491050071.SGD","LU2552382132.HKD","IHE","LU2491050154.USD","LU0385154629.USD","LU0353189680.USD","PJP","BK4581","LU0345770993.USD","JPMO","LU1084165304.USD","LU0354030511.USD","TMED","LU0708995401.HKD","LU2111349929.HKD","LU0106831901.USD","LU1291159041.SGD","SGXZ99366536.SGD","LU0882574055.USD","LU2756315318.SGD","VFH","LU0122379950.USD","LU2896262040.SGD","LU0058720904.USD","IE00BYXW3230.USD","LU1988902786.USD","AGNG","LU0353189763.USD","LU2244417387.USD","LU2324357040.USD","LU1323610961.USD","LU1894683264.USD","LU2505996509.AUD","LU2106854487.HKD","LLII","PPH","LU2552382215.SGD","LU1061106388.HKD","IE000M9KFDE8.USD","LU0323591593.USD","GDOC","LU1914381329.SGD","LU1496350171.SGD","IYG","LU1023059063.AUD","LU2602419157.SGD","LU2592432038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","LU1718418525.SGD","JDOC","IE00B4R5TH58.HKD","ABBV","LU0553294199.USD","LU0708994859.HKD","BK4137","BK4534","LU2237443382.USD","LU0203345920.USD","LU2125909593.SGD","RARE","LU1244550577.SGD","HCM","HCSG","MEDX","IE00BJJMRZ35.SGD","IBB","APGE","TRUH","LU0432979614.USD","VHT","IE00BGHQF631.EUR","GSK","GLAM","LU0114720955.EUR","IXJ","FHLC","LU0124676726.USD","LU1496350171.SGD","LU1989772923.USD","PPH","LU0289961442.SGD","XLV","FTXH","GSKH","XBI","LU0820561909.HKD","IYH","LU0256863811.USD","LU1236620750.USD","SBIO","LU0029864427.USD","PJP","RXL","AGNG","IE0004445239.USD","LABU","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880504","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664880504?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:39","pubTimestamp":1788457140,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2265009873.SGD","LU2168563687.JPY","IE0001KFT4U8.USD","LU2361044865.SGD","LU2750360641.GBP","LLYZ","LU0354030511.USD","BK4599","GNOM","LU0096364046.USD","LU2471134796.USD","ELIL","TMED","LU1548497426.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0640476718.USD","IE00B7KXQ091.USD","IE0005OL40V9.USD","LU0158827948.USD","LU0234572021.USD","LU1804176565.USD","BK4548","LU2237438978.USD","LU2750360997.AUD","SGXZ31699556.SGD","LU2552382132.HKD","LU2028103732.USD","LU0786609619.USD","LU1720051017.SGD","LU2271345857.HKD","BK4585","LU1035775433.USD","LU0882574139.USD","IE00BKDWB100.SGD","LU0345770308.USD","LU1623119135.USD","LU0198837287.USD","LU1093756168.USD","LU0823434740.USD","LU1720051108.HKD","LU2237443382.USD","LU2552382215.SGD","LU0353189680.USD","LU1057294990.SGD","IE00B1BXHZ80.USD","IBB","LLY","LU0316494557.USD","LU0320765992.SGD","LU2211815571.USD","SG9999014898.SGD","LLYX","LU1814569148.SGD","LU2896262040.SGD","LU2756315664.SGD","LU0094547139.USD","LU1979441026.SGD","IHE","LU0943347566.SGD","SG9999014906.USD","LU2361045086.USD","XLV","LU0823416689.USD","IE00B4R5TH58.HKD","LU0471298694.HKD","LU1232071149.USD","IE00BN29S564.USD","LU0097036916.USD","LU2417539215.USD","LU2462157665.USD","LU1868836914.USD","LU1064131342.USD","LU0133085943.USD","LU0323591593.USD","LU2456880835.USD","HRTS","LLII","LU0385154629.USD","LU2237443895.HKD","IE00BJJMRY28.SGD","LU0466842654.USD","LU0238689110.USD","JDOC","LU2213496289.HKD","ILDR","LU0456855351.SGD","WDNA","LU1868837300.USD","LU2471134952.CNY","IE00BK4W5L77.USD","LU0079474960.USD","IE0009355771.USD","LU1712237335.SGD","LU2462591350.SGD","LU2746668974.SGD","LU0210536198.USD","BK4534","LU0122379950.USD","LU0417517546.SGD","IE00B4JS1V06.HKD","SG9999017495.SGD","LU0114720955.EUR","LU2746668461.USD","LU2023250504.SGD","MHIP","SG9999015986.USD","IE00B1XK9C88.USD","LU1974910355.USD","LU1868836591.USD","IE00BK4W5M84.HKD","LU0203201768.USD","LU1551013342.USD","LU2089283258.USD","LU1868837136.USD","MRNA","THNR","LU1127390331.HKD","CANC","IE00BWXC8680.SGD","LU2089984988.USD","SG9999001176.USD","SG9999014880.SGD","IE00B775H168.HKD","LU2491050154.USD","OZEM","IE00BFSS8Q28.SGD","LGHT","LU2111349929.HKD","IE00B2B36J28.USD","LU0109394709.USD","TRUH","LU0174119429.USD","IE00BJLML261.HKD","LU1291159041.SGD","LU0320765059.SGD","LU0823434583.USD","LU2237443549.SGD","LU2552382058.USD","LU2168564495.EUR","IE00BFSS7M15.SGD","LU1145028129.USD","LU0225283273.USD","LU2023250330.USD","SG9999018865.SGD","MRNX","LU1267930730.SGD","LU2237443622.USD","LU0061475181.USD","MEDI","BK4501","LU1323610961.USD","LU0109391861.USD","ELIS","IE00BJT1NW94.SGD","LU1093756325.SGD","IE0002141913.USD","PJP","LU1691799644.USD","LU0708995401.HKD","LU2471134523.USD","LU0106261372.USD","RXL","LU0432979614.USD","LU1629891620.HKD","SGXZ99366536.SGD","LU1280957306.USD","IDNA","LU0889565916.HKD","LU2112291526.USD","LU0820562030.AUD","LU1917777945.USD","LU0787776722.HKD","MRNY","SGXZ51526630.SGD","BK4588","SGXZ81514606.USD","BK4007","LU0964807845.USD","LU1551013425.SGD","IE00BKPKM429.USD","GDOC","LU2471134879.HKD","LU0471298777.SGD","BK4551","IE0004445239.USD","AGNG","SG9999018857.SGD","BK4139","LU2023251221.USD","GB00BDT5M118.USD","LU0006306889.USD","LU0256863902.USD","LU0266013472.USD","LU0820561909.HKD","BK4532","LU1868836757.USD","SG9999001176.SGD","LU0354030438.USD","PPH","SG9999013999.USD","LABU","LU0672654240.SGD","BK4516","BK4533","LU0158827781.USD","LU2468319806.SGD","FTXH","SG9999014914.USD","LU1988902786.USD","LU2491049909.HKD","LU0256863811.USD","LU2108987350.USD","MEDX","LU0345770993.USD","LU0353189763.USD","LU1069344957.HKD","SGXZ57979304.SGD","LU1366192091.USD","LU0058720904.USD","LU1061106388.HKD","IE0004445015.USD","LU0882574055.USD","LU2360106947.USD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU2461242641.AUD","LU2087625088.SGD","LU0820561818.USD","LU2756315318.SGD","LU2236285917.USD","SG9999015952.SGD","LU1989771016.USD","LU2324357040.USD","LU0683600562.USD","LU0289739699.SGD","LU2168564222.USD","SG9999015978.USD","XBI","LU2264538146.SGD","FHLC","BK4581","LU2237443465.HKD","LU0203202063.USD","LU2168564149.EUR","LU2357305700.SGD","LU2361044949.HKD","LU2602419157.SGD","IE00BJJMRX11.SGD","BK4568","LU1983299246.USD","SG9999015945.SGD","LU2106854487.HKD","LU2063271972.USD","LU2168564065.EUR","LU0689472784.USD","LU2237443978.SGD","LU2491050071.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805360","title":"Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805360?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453049,"startTime":"0","endTime":"0","summary":"Eisai Co ($ESALF) announced an update on their ongoing clinical study. The Phase 3 LEAP-012 study, run by Merck Sharp & Dohme with Eisai as partner...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eisais-lenvima-combo-trial-in-liver-cancer-ends-with-mixed-but-market-relevant-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eisais-lenvima-combo-trial-in-liver-cancer-ends-with-mixed-but-market-relevant-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IHE","TRUH","LU0238689110.USD","BK4550","FHLC","LU2125154778.USD","XLV","LU0208291251.USD","IE00BLSP4239.USD","SG9999001176.SGD","FTXH","LU1037948897.HKD","PPH","BK4588","LU0124676726.USD","LU0211331839.USD","LU1989771016.USD","LU2125909247.SGD","VHT","LU0320765489.SGD","LU1057294990.SGD","LU1061106388.HKD","PAWZ","LU0265550359.USD","GDOC","BMED","IE00BN8TJ469.HKD","LU0477156953.USD","LU1934455863.HKD","LU1974910355.USD","IE0009355771.USD","LU2361044865.SGD","RXL","HRTS","MRK","LU2360032135.SGD","BK4585","LU0868494617.USD","JDOC","IE00B4R5TH58.HKD","LU1585245621.USD","IXJ","SG9999015358.SGD","LU2468319806.SGD","LU1201861249.SGD","BK4007","LU0859254822.USD","SG9999002224.SGD","IYH","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664031788","title":"Summit Therapeutics Says it is Beating Merck with Its Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664031788","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664031788?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:00","pubTimestamp":1788451200,"startTime":"0","endTime":"0","summary":"Shares of the drug developer Summit Therapeutics were up more than 12% Thursday morning on news that its drug is performing well in a Chinese lung cancer study.Summit stock jumped to $16.46 after the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250843.SGD","LU0432979614.USD","VHT","IE00B1BXHZ80.USD","LU0106261372.USD","LU0985320562.USD","LU0058720904.USD","HRTS","PAWZ","BK4585","LU0203345920.USD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4534","LU0238689110.USD","LU2360032135.SGD","LU0130102774.USD","LU1116320901.HKD","IE00BJT1NW94.SGD","SG9999002224.SGD","LU2324357040.USD","LU1989771016.USD","LU0965508806.USD","SG9999001176.USD","LU2125909247.SGD","LU2433249047.HKD","IE00B4R5TH58.HKD","LU1032466523.USD","SG9999015341.SGD","LU1162221912.USD","LU1941712348.USD","LU1093756325.SGD","LU1035773651.USD","LU0122379950.USD","LU1917777945.USD","LU0006306889.USD","LU1929549753.HKD","BK4533","LU2361044949.HKD","LU2468319806.SGD","BK4139","LU1699723380.USD","IHE","LU1116320737.USD","LU0208291251.USD","LU1934455277.USD","LU0648001328.SGD","LU0868494617.USD","SG9999001176.SGD","LU1983299246.USD","FTXH","LU1057294990.SGD","LU2491049909.HKD","LU0965509101.SGD","SGXZ57979304.SGD","LU1430594728.SGD","LU0265550359.USD","LU1037948897.HKD","SG9999013999.USD","IXJ","LU0266013472.USD","SG9999001440.SGD","LU1037948541.HKD","LU2461242641.AUD","LU2491050154.USD","LU1066053197.SGD","LU0689626769.HKD","LU1989772840.SGD","SG9999014567.USD","LU1989772923.USD","LU0868494708.USD","SG9999014542.SGD","LU1066051225.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU2125909593.SGD","IE00BFTCPJ56.SGD","LU0980610538.SGD","RXL","LU2089984988.USD","XLV","MRK","LU2491050071.SGD","LU2357627491.SGD","LU1941712264.USD","LU2106854487.HKD","LU1093756168.USD","LU1571399168.USD","LU1201861249.SGD","LU0289739699.SGD","LU2125154935.USD","JDOC","LU1585245621.USD","IE0009355771.USD","GDOC","BK4588","IE000M9KFDE8.USD","LU0203347892.USD","LU0211331839.USD","LU1934455863.HKD","BK4550","LU0823416689.USD","LU0861579265.USD","LU0965509283.SGD","SMMT","LU0965509010.AUD","LU0130517989.USD","LU2488822045.USD","IE00BSNM7G36.USD","PPH","LU2361045086.USD","LU0477156953.USD","LU0320765646.SGD","IE00BN8TJ469.HKD","LU1923622614.USD","IE0002141913.USD","LU1066051498.USD","IE00B2B36J28.USD","LU0070302665.USD","LU1974910355.USD","LU1061106388.HKD","SG9999014559.SGD","IE00BJJMRZ35.SGD","LU1069347547.HKD","LU0234572021.USD","LU2023250504.SGD","LU0124676726.USD","BK4559","LU2125154778.USD","BMED","LU2361044865.SGD","FHLC","SG9999014575.USD","LU1291159041.SGD","BK4007","SG9999015358.SGD","BK4516","IYH","TRUH","LU0098860793.USD","SG9999002232.USD","LU1934455194.USD","LU0265550946.USD","LU1066051811.HKD","LU0859254822.USD","LU0942090050.USD","LU2112291526.USD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870565","title":"AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870565","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870565?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:07","pubTimestamp":1788444473,"startTime":"0","endTime":"0","summary":"AbbVie's (ABBV) phase 3 study of etentamig in patients with triple-class exposed relapsed/refractory multiple myeloma met its dual primary endpoints of objective response rate and progression-free sur","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","LU0820561909.HKD","IE0004445239.USD","PPH","IE00BJT1NW94.SGD","RXL","SG9999015952.SGD","FHLC","LU1057294990.SGD","LU0661504455.SGD","TRUH","LU2468319806.SGD","LU1923622614.USD","LU2237443549.SGD","IE00BVYPNW00.USD","LU0320765646.SGD","FTXH","GLAM","LU0289739699.SGD","LU1670628061.USD","IE000SO60NU8.SGD","SG9999001440.SGD","PJP","MEDX","SG9999003800.SGD","LU2357627491.SGD","VHT","LU0965509010.AUD","AGNG","IYH","LU0256863902.USD","LU0456855351.SGD","LU1718418525.SGD","LU0965509283.SGD","IXJ","BK4581","LU0289739343.SGD","ABBV","LU1267930490.SGD","LU1732799900.SGD","IE00BGHQF631.EUR","IE00BBT3K403.USD","JDOC","XLV","LU2129689514.USD","IE0009355771.USD","SG9999015986.USD","LU2237443465.HKD","LU2433249047.HKD","IE000WAW04H5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587722","title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587722","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587722?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:42","pubTimestamp":1788442920,"startTime":"0","endTime":"0","summary":"AbbVie said a drug to treat blood cancer met its dual primary endpoints in a phase 3 study.The company said etentamig demonstrated a significantly higher objective response rate and improvements in pr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","LU0289961442.SGD","IE00B42XCP33.USD","TRUH","PPH","IE00BBT3K403.USD","SG9999001440.SGD","IXJ","LU0170899867.USD","LU0211328371.USD","ABBV","AGNG","IE000BZT7R73.USD","IE00BVYPNV92.GBP","LU1291159041.SGD","PJP","JDOC","LU1003077747.HKD","IE000F7OJYX1.SGD","FTXH","LU0203347892.USD","LU0859254822.USD","LU1093756325.SGD","LU1732799900.SGD","LU0256863902.USD","RXL","FHLC","LU0868494617.USD","IE00BLSP4452.SGD","IE0000B7K699.USD","LU0472753341.HKD","LU0124676726.USD","BK4585","LU2237443978.SGD","LU1244550221.USD","LU2112291526.USD","XLV","LU1989771016.USD","LU2129689431.USD","LU0861579265.USD","IE00BDGV0183.EUR","LU0823416689.USD","GLAM","IYH","MEDX","LU0868494708.USD","LU1551013342.USD","IE00B19Z3B42.SGD","LU2089283258.USD","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587723","title":"AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587723","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587723?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:25","pubTimestamp":1788441947,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced positive topline results from the Phase 3 Cervino study evaluating etentamig, an investigational BCMA x CD3 bispecific T-ce...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203347892.USD","LU1093756325.SGD","LU0320765646.SGD","ABBV","LU0942090050.USD","LU2357627491.SGD","IE00BLSP4239.USD","FHLC","IE000WAW04H5.SGD","BK4550","SG9999011175.SGD","IYH","LU0417517546.SGD","TRUH","LU0912757837.SGD","LU0472753341.HKD","LU0795875169.SGD","GLAM","LU0868494617.USD","LU0057025933.USD","IXJ","MEDX","AGNG","LU1057294990.SGD","LU2089284900.SGD","BK4585","PPH","LU1929549753.HKD","LU1585245621.USD","LU2237443465.HKD","ORR","LU1244550494.USD","LU2129689431.USD","VHT","LU0124676726.USD","LU0882574055.USD","LU0256863811.USD","PJP","JDOC","IE000F7OJYX1.SGD","LU0820561909.HKD","XLV","BK4559","FTXH","LU1496350171.SGD","IE0004445239.USD","LU0965509283.SGD","RXL","LU1989772840.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877895","title":"AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877895","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877895?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441527,"startTime":"0","endTime":"0","summary":"AbbVie's blood cancer drug meets late-stage trial goalsSept 3 (Reuters)-AbbVieABBV.Nsaid on Thursday its drug for a type of blood cancer has met the main goals of a late-stage trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","LU0203345920.USD","LU0114720955.EUR","LU0726765562.USD","RXL","ABBV","LU2112291526.USD","LU0820561909.HKD","BK4585","IE000MB6IJN5.SGD","LU0472753341.HKD","PPH","LU1496350171.SGD","IE00BVYPNW00.USD","XLV","IE00BLSP4239.USD","LU0256863902.USD","LU2089283258.USD","LU1585245621.USD","IYH","AGNG","IXJ","LU1934455277.USD","MEDX","PJP","LU1989772923.USD","LU0985320562.USD","SG9999001440.SGD","TRUH","SG9999015945.SGD","JDOC","FTXH","IE00BBT3K403.USD","LU0128525929.USD","LU1934455863.HKD","IE00BN8TJ469.HKD","SG9999015952.SGD","LU0289961442.SGD","LU0942090050.USD","IE0009355771.USD","LU0057025933.USD","LU0211328371.USD","LU0098860793.USD","IE00B3PB1722.GBP","VHT","FHLC","LU0395794307.EUR","IE0004445239.USD","LU2357627491.SGD","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887207","title":"Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887207?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU1718418525.SGD","LU0122379950.USD","LU0234572021.USD","LU2087621335.USD","LU0859254822.USD","IE00BBT3K403.USD","FTXH","LU1244550577.SGD","TRUH","IYH","LU2237443549.SGD","LU1291159041.SGD","LU1496350171.SGD","LU0114720955.EUR","PJP","LU2089984988.USD","LU2347655073.USD","LU1244550221.USD","LU1585245621.USD","LU2125909593.SGD","LU1670628061.USD","MEDX","LU1236620834.HKD","LU0965509010.AUD","AGNG","IXJ","LU1983299246.USD","PPH","LU1057294990.SGD","LU2133065610.SGD","LU1093756325.SGD","LU1551013425.SGD","LU1839511570.USD","IE00B4R5TH58.HKD","LU0553294199.USD","LU0511384066.AUD","JDOC","LU0098860793.USD","ABBV","GLAM","FHLC","LU1023059063.AUD","LU0689472784.USD","LU0820561909.HKD","VHT","XLV","RXL","IE00BN8TJ469.HKD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872073","title":"Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872073?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PJP","LU2237443465.HKD","LU0795875169.SGD","LU2089283258.USD","FTXH","IYH","LU1732800096.USD","LU1839511570.USD","LU1934455194.USD","ABBV","SG9999011175.SGD","XLV","LU0234572021.USD","LU2237443382.USD","LU0545039389.USD","SG9999003800.SGD","IXJ","LU1244550494.USD","IE00BBT3K403.USD","BK4588","TRUH","LU0128525929.USD","LU0456855351.SGD","LU1989771016.USD","LU0859254822.USD","LU1244550577.SGD","SG9999001440.SGD","IE00B19Z3B42.SGD","GLAM","LU1430594728.SGD","LU1093756325.SGD","LU2125909593.SGD","PPH","LU0170899867.USD","IE00B3PB1722.GBP","LU1934455863.HKD","MEDX","FHLC","SG9999015945.SGD","IE00B2B36J28.USD","VHT","LU0861579265.USD","LU0943347566.SGD","JDOC","LU0289961442.SGD","RXL","LU0511384066.AUD","LU0942090050.USD","IE000WAW04H5.SGD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720768","title":"Abbvie - Etentamig Achieves 74% Orr and 60% Risk Reduction in Phase 3 Cervino Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720768?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739343.SGD","TRUH","LU2133065610.SGD","PPH","LU0545039389.USD","LU0417517546.SGD","RXL","FHLC","FTXH","LU1934455194.USD","LU0726765562.USD","LU1093756325.SGD","LU0868494708.USD","LU0432979614.USD","LU0965508806.USD","ABBV","LU0170899867.USD","LU2237443382.USD","GLAM","LU1983299246.USD","LU0882574055.USD","IXJ","JDOC","SG9999011175.SGD","BK4588","LU1670628061.USD","VHT","AGNG","LU0861579265.USD","IE000MB6IJN5.SGD","LU1244550577.SGD","LU1934455277.USD","LU0689472784.USD","LU1236620834.HKD","LU1929549753.HKD","XLV","PJP","IE00BJJMRZ35.SGD","LU0859254822.USD","MEDX","BK4533","IE000SO60NU8.SGD","LU1003077747.HKD","LU0795875169.SGD","BK4139","LU0965509283.SGD","IYH","IE000BZT7R73.USD","IE00BJT1NW94.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487207","title":"Abbvie Announces Positive Topline Results from the Phase 3 Cervino Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487207?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965508806.USD","LU0820561818.USD","LU1244550577.SGD","LU0310800379.SGD","LU2357627491.SGD","LU0417517546.SGD","PPH","IE000F7OJYX1.SGD","LU0432979614.USD","LU0128525929.USD","IE000BZT7R73.USD","LU1923622614.USD","LU0203347892.USD","LU0289961442.SGD","LU1670627923.USD","TRUH","RXL","FTXH","AGNG","LU2129689605.HKD","MEDX","LU1093756325.SGD","VHT","LU0310799852.SGD","ABBV","BK4533","IE0004445239.USD","IE000MB6IJN5.SGD","FHLC","LU1989772923.USD","PJP","IE00B4R5TH58.HKD","LU0198837287.USD","LU1244550221.USD","LU0511384066.AUD","LU0820561909.HKD","GLAM","XLV","LU1934455863.HKD","BK4139","IE0002141913.USD","LU0965509010.AUD","LU2237443622.USD","IE000SO60NU8.SGD","IYH","LU1244550494.USD","LU0456855351.SGD","JDOC","IE00BLSP4452.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720938","title":"AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720938","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:13","pubTimestamp":1788441193,"startTime":"0","endTime":"0","summary":"AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share.The acquisition is expected to negatively impact adjusted diluted earnings per share by $0.14 in 2026 and by approximately $0.46 in 2027, with accretion beginning in 2032, AbbVie said.Apogee Therapeutics' stock ceased trading on the Nasdaq stock exchange prior to the market open on Sept. 3, according to a statement.AbbVie said it continues to expect Q3 adjusted diluted EPS in the range of $3.84 to $3.88, and full-year adjusted diluted EPS between $13.87 to $14.07.Analysts polled by FactSet expect $3.86 and $14.03, respectively.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FTXH","LU0795875086.SGD","LU1923622614.USD","LU0795875169.SGD","PJP","XLV","AGNG","RXL","JDOC","LU1093756325.SGD","IXJ","IYH","LU0965509101.SGD","LU0985320562.USD","LU0069063385.USD","LU2129689514.USD","LU0310799852.SGD","LU1244550494.USD","IE00BVYPNV92.GBP","APGE","LU0432979614.USD","LU0949170772.SGD","LU2237443382.USD","TRUH","LU1061106388.HKD","PPH","LU0456855351.SGD","LU0965509010.AUD","MEDX","LU2237443622.USD","LU0738911758.USD","SG9999011175.SGD","LU1267930573.SGD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU0417517546.SGD","LU0289739343.SGD","SBIO","IE00B19Z3B42.SGD","ABBV","LU1037948897.HKD","LU0289961442.SGD","LU0057025933.USD","LU1023059063.AUD","LU2089283258.USD","GLAM","FHLC","LU0320765646.SGD","LU2125909247.SGD","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872503","title":"Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872503","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872503?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:54","pubTimestamp":1788440071,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics shares face Nasdaq suspension as company moves to delist after AbbVie mergerApogee notified Nasdaq of its merger close, requesting delisting and continued trading halt; shares suspended from trading Sept. 4, 2026.Nasdaq to file SEC Form 25 to delist and deregister the stock under Exchange Act Section 12.Company plans to file SEC Form 15 to terminate registration under Section 12, suspending reporting obligations under Sections 13 and 15.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 03, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3D254h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU2237443549.SGD","LU1670627923.USD","LU2468319806.SGD","PJP","RXL","ABBV","LU0320765646.SGD","LU0943347566.SGD","IE00BN8TJ469.HKD","LU0882574055.USD","VHT","XLV","LU1934455277.USD","LU2237443895.HKD","LU0128525929.USD","LU1061106388.HKD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU2089284900.SGD","IE000MB6IJN5.SGD","LU2129689514.USD","FTXH","SG9999003800.SGD","LU1023059063.AUD","BK4534","JDOC","GLAM","IE00B3PB1722.GBP","APGE","LU2347655073.USD","IE00B19Z3581.USD","SBIO","FHLC","LU0965508806.USD","IXJ","LU1989771016.USD","IE00B4R5TH58.HKD","MEDX","IYH","TRUH","LU0868494708.USD","LU0965509010.AUD","LU2237443382.USD","LU2347655156.SGD","IE000F7OJYX1.SGD","LU2112291526.USD","LU0820561909.HKD","PPH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":204,"code":"91000000","status":"200"}]}}